James Bearden to Ketamine
This is a "connection" page, showing publications James Bearden has written about Ketamine.
Connection Strength
0.082
-
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41.
Score: 0.082